)
Musheng Bao
Head of Biology,
Nona Biosciences
Dr. Musheng Bao earned his Ph.D. in China and completed postdoctoral training at MD Anderson Cancer Center and Baylor Institute for Immunology Research. Transitioning to industry, he held positions at MedImmune and later at Sanofi. He then joined Harbour BioMed, leading a team dedicated to therapeutic antibody development utilizing the Harbour Mice® platform. Presently, Dr. Bao serves as Head of Biology at Nona Biosciences. Throughout his career, he has been actively involved in diverse professional pursuits spanning industry and research, with a primary focus on the intersection of immune-oncology, autoimmune diseases, and cell therapies.